The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells
Authors:
- Mathias P. ClausenMCMathias P. Clausen
- Martin V. BennetzenMBMartin V. Bennetzen
- Ole G. MouritsenOMOle G. Mouritsen
- Barbara GuerraBarbara Guerra
- 1 September 2009
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 20 (8) , 723-735
Abstract
Tamoxifen resistance is a major clinical problem in the treatment of estrogen receptor α-positive breast tumors. It is, at present, unclear what exactly causes tamoxifen resistance. For decades, chlorpromazine has been used for treating psychotic diseases, such as schizophrenia. However, the compound is now also recognized as a multitargeting drug with diverse potential applications, for example, it has antiproliferative properties and it can reverse resistance toward antibiotics in bacteria. Furthermore, chlorpromazine can reverse multidrug resistance caused by overexpression of P-glycoprotein in cancer cells. In this study, we have investigated the effect of chlorpromazine on tamoxifen response of human breast cancer cells. We found that chlorpromazine worked synergistically together with tamoxifen with respect to reduction of cell growth and metabolic activity, both in the antiestrogen-sensitive breast cancer cell line, MCF-7, and in a tamoxifen-resistant cell line, established from the MCF-7 cells. Tamoxifen-sensitive and tamoxifen-resistant cells were killed equally well by combined treatment with chlorpromazine and tamoxifen. This synergistic effect could be prevented by addition of estrogen, suggesting that chlorpromazine enhances the effect of tamoxifen through an estrogen receptor-mediated mechanism. To investigate this putative mechanism, we applied biophysical techniques to simple model membranes in the form of unilamellar liposomes of well-defined composition and found that chlorpromazine interacts strongly with lipid bilayers of different composition leading to increased permeability. This implies that chlorpromazine can change influx properties of membranes hence suggesting that chlorpromazine may be a promising chemosensitizing compound for enhancing the cytotoxic effect of tamoxifen.Keywords
This publication has 39 references indexed in Scilit:
- Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activitiesInternational Journal of Antimicrobial Agents, 2008
- Pathways to tamoxifen resistanceCancer Letters, 2007
- Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.Current Drug Targets, 2006
- Evolution of antipsychotic intervention in the schizophrenic psychosis.Current Drug Targets, 2006
- Endocrine therapy – current benefits and limitationsBreast Cancer Research and Treatment, 2005
- Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytesCancer Chemotherapy and Pharmacology, 2004
- Inactivation of Cholinesterase Induced by Chlorpromazine Cation RadicalsBasic & Clinical Pharmacology & Toxicology, 2003
- Effects of psychotropic drugs on cell proliferation and differentiationBiochemical Pharmacology, 1999
- Mechanisms of Tamoxifen Resistance in the Treatment of Advanced Breast CancerActa Oncologica, 1996
- Pharmacokinetic Analysis of Chlorpromazine in Rat Serum, Cerebrospinal Fluid and Striatum.Biological and Pharmaceutical Bulletin, 1995